Download image:

Bradford B. Walters

Vice President and Chief Medical Officer

Brad Walters, MD, PhD, MBA, is a vice president and the chief medical officer of RTI International. After completing his PhD, MD, a surgical internship, and a neurosurgical residency, he joined the faculty of the University of North Carolina at Chapel Hill School of Medicine, where he assisted in establishing the radiosurgery program and the epilepsy surgery program. His research focused on central nervous system trauma. After completing his MBA, he joined Academy Funds serving as principal and then partner, and on the boards of directors of Kucera Pharmaceutical Company, ParinGenix, and Curry Pharmaceuticals. He was then appointed a member of the Building Entrepreneurial Companies Work Group of the North Carolina Biotechnology Center Strategic Plan, and to the Governor's Task Force on Nanotechnology and North Carolina's Economy. From 1999 through 2006, he served as a member of the board of directors of NCHICA. Dr. Walters has brought three new chemical entities into five Phase I clinical trials.


PhD, Anatomy and Embryology, University of London; MD (cum laude), Harvard Medical School/Massachusetts Institute of Technology Division of Health Sciences and Technology; MBA, Kenan-Flagler Business School, University of North Carolina at Chapel Hill; AB, Chemistry and Physics (summa cum laude), Harvard College.

Latest Publications

Marsden Jr., W.E., Fedenisn, A., Greer, J.A., Herstein, J., Powers, M.K., Sampson, J.M., Sax, E.W., Vosburgh, K., Walsh, K.F., Walters, B.B., et al. (December 2014). Ebola as an organizational policy challenge: A brief primer: RTI Press Publication No. PB-0006-1412. Research Triangle Park, NC: RTI Press.
Walters, B.B. (2014). Neurological adverse events. In Andrews, E.B. & Moore, N. (Eds.), Mann's Pharmacovigilance (3rd ed.) (pp. 585-610). Chichester, UK: Wiley-Blackwell.
Rao, N.V., Argyle, B., Xu, X.Y., Reynolds, P.R., Walenga, J.M., Prechel, M., Prestwich, G.D., MacArthur, R.B., Walters, B.B., et al. (2010). Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands. American Journal of Physiology. Cell Physiology, 299 (1):C97-C110.
Thompson, J.E., Castillo, M., Kwock, L., & Walters, B. (1998). Usefulness of proton MR spectroscopy in the evaluation of temporal lobe epilepsy. American Journal of Roentgenology (AJR), 170 (3):771-776.
Walters, B.B., Bachman, E.S., & Houston, A.E. (1993). Functional and histological effects of locally applied extracellular matrix with and without bFGF following spinal cord transection. Society for Neuroscience Abstracts, 19 :1103.
View all publications by Bradford B. Walters (11)